Prehabilitation is a multimodal strategy involving physical exercise as well as nutritional and psychosocial interventions aimed at improving fitness in the preoperative period. It is also used to improve and support patient tolerance and outcomes from treatments such as chemotherapy, radiotherapy, and immunotherapy.
Join a multidisciplinary team of nursing and allied health professionals as they discuss how prehabilitation can be used to optimize thoracic oncology patients prior to treatment and support them throughout their journey. This is part two of a two-part series that aims to comprehensively present the key aspects of prehabilitation, including a scientific overview of benefits, organizing a program, physical conditioning and strengthening strategies prior to and during treatment, nutritional support, and psychological/motivational support.
These webinars aim to address not only the reasons why prehabilitation is pivotal to optimizing patient care, and survivorship, but the wider scope of its implementation in the thoracic oncology cancer pathway.
Tuesday, July 13
2 PM MDT, 4 PM EDT, 9 PM UK, 10 PM CEST
Wednesday, July 14
6 AM AEDT
A one-hour webinar consisting of three, 15-minute presentations on prehabilitation. There will be 15 minutes allotted to Q&A with the viewers.
At the conclusion of this activity, participants will be able to:
1. Summarize the rationale and evidence behind prehabilitation. This will include beneficial outcomes as functional capacity and reduced hospital stay.
2. Describe objective measures used to determine functional capacity in patients with lung cancer.
3. Describe the role nutrition plays in the care of lung cancer patients before, during, and after treatment.
4. Explain the emotional concerns lung cancer patients may have related to pre-habilitation and describe supportive strategies.
This webinar is designed to meet the educational needs of physicians, researchers, patient advocates, and nurse and allied health professionals specializing in palliative care, medical oncology, radiation oncology, and thoracic surgery.
Accreditation Statement
The International Association for the Study of Lung Cancer is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The International Association for the Study of Lung Cancer designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Stephen Wootton, PhD, FAfN, OBE discloses he is on an advisory board and has an investigator-led institutional collaborative research agreement with Seca GmBH.
None of the other planners, reviewers, and staff for this activity reported any relevant financial relationships.
Tuesday, July 13
2 PM MDT, 4 PM EDT, 9 PM UK, 10 PM CEST
Wednesday, July 14
6 AM AEDT
A one-hour webinar consisting of three, 15-minute presentations on prehabilitation. There will be 15 minutes allotted to Q&A with the viewers.
At the conclusion of this activity, participants will be able to:
1. Summarize the rationale and evidence behind prehabilitation. This will include beneficial outcomes as functional capacity and reduced hospital stay.
2. Describe objective measures used to determine functional capacity in patients with lung cancer.
3. Describe the role nutrition plays in the care of lung cancer patients before, during, and after treatment.
4. Explain the emotional concerns lung cancer patients may have related to pre-habilitation and describe supportive strategies.
This webinar is designed to meet the educational needs of physicians, researchers, patient advocates, and nurse and allied health professionals specializing in palliative care, medical oncology, radiation oncology, and thoracic surgery.
Accreditation Statement
The International Association for the Study of Lung Cancer is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The International Association for the Study of Lung Cancer designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Stephen Wootton, PhD, FAfN, OBE discloses he is on an advisory board and has an investigator-led institutional collaborative research agreement with Seca GmBH.
None of the other planners, reviewers, and staff for this activity reported any relevant financial relationships.